Cargando…
COVID-19 : encore une place pour le tocilizumab ?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691818/ https://www.ncbi.nlm.nih.gov/pubmed/33288230 http://dx.doi.org/10.1016/j.revmed.2020.11.016 |
| _version_ | 1783614374919798784 |
|---|---|
| author | Richier, Q. Plaçais, L. Lacombe, K. Hermine, O. |
| author_facet | Richier, Q. Plaçais, L. Lacombe, K. Hermine, O. |
| author_sort | Richier, Q. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7691818 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76918182020-11-27 COVID-19 : encore une place pour le tocilizumab ? Richier, Q. Plaçais, L. Lacombe, K. Hermine, O. Rev Med Interne Éditorial Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. 2021-02 2020-11-27 /pmc/articles/PMC7691818/ /pubmed/33288230 http://dx.doi.org/10.1016/j.revmed.2020.11.016 Text en © 2020 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Éditorial Richier, Q. Plaçais, L. Lacombe, K. Hermine, O. COVID-19 : encore une place pour le tocilizumab ? |
| title | COVID-19 : encore une place pour le tocilizumab ? |
| title_full | COVID-19 : encore une place pour le tocilizumab ? |
| title_fullStr | COVID-19 : encore une place pour le tocilizumab ? |
| title_full_unstemmed | COVID-19 : encore une place pour le tocilizumab ? |
| title_short | COVID-19 : encore une place pour le tocilizumab ? |
| title_sort | covid-19 : encore une place pour le tocilizumab ? |
| topic | Éditorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691818/ https://www.ncbi.nlm.nih.gov/pubmed/33288230 http://dx.doi.org/10.1016/j.revmed.2020.11.016 |
| work_keys_str_mv | AT richierq covid19encoreuneplacepourletocilizumab AT placaisl covid19encoreuneplacepourletocilizumab AT lacombek covid19encoreuneplacepourletocilizumab AT hermineo covid19encoreuneplacepourletocilizumab |